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Abstract
Activation-induced deaminase (AID) initiates secondary antibody
diversification in germinal center B cells, giving rise to higher
affinity antibodies through somatic hypermutation (SHM) or to
isotype-switched antibodies through class switch recombination
(CSR). SHM and CSR are triggered by AID-mediated deamination of
cytosines in immunoglobulin genes. Importantly, AID activity in B
cells is not restricted to Ig loci and can promote mutations and
pro-lymphomagenic translocations, establishing a direct oncogenic
mechanism for germinal center-derived neoplasias. AID is also
expressed in response to inflammatory cues in epithelial cells,
raising the possibility that AID mutagenic activity might drive
carcinoma development. We directly tested this hypothesis by
generating conditional knock-in mouse models for AID overexpres-
sion in colon and pancreas epithelium. AID overexpression alone
was not sufficient to promote epithelial cell neoplasia in these
tissues, in spite of displaying mutagenic and genotoxic activity.
Instead, we found that heterologous AID expression in pancreas
promotes the expression of NKG2D ligands, the recruitment of
CD8+ T cells, and the induction of epithelial cell death. Our results
indicate that AID oncogenic potential in epithelial cells can be
neutralized by immunosurveillance protective mechanisms.
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Introduction
Activation-induced deaminase (AID) is the enzyme that initiates the
reactions of secondary antibody diversification: somatic hypermuta-
tion (SHM) and class switch recombination (CSR) (Muramatsu et al,
2000). These reactions enable the generation of antibodies with
increased affinity for antigen (SHM) and with diversified, special-
ized functions for antigen removal (CSR), and are therefore critical
for a competent immune response (Di Noia & Neuberger, 2007;
Stavnezer et al, 2008; Alt et al, 2013; Robbiani & Nussenzweig,
2013). Accordingly, defective AID activity promotes a Hyper-IgM
immunodeficiency syndrome in humans (Revy et al, 2000). AID
triggers SHM and CSR by direct deamination of cytosine nucleosides
in the DNA of immunoglobulin genes, resulting in the generation of
U:G mismatches (Petersen-Mahrt et al, 2002; Alt et al, 2013;
Robbiani & Nussenzweig, 2013). These U:G mismatches are in turn
processed by alternative repair pathways that ultimately lead in
SHM to the fixation of a mutation, and in CSR to a DNA double-
strand break (DSB) and a recombination reaction (Di Noia &
Neuberger, 2007; Stavnezer et al, 2008; Alt et al, 2013; Robbiani &
Nussenzweig, 2013).
Activation-induced deaminase activity is not confined to
immunoglobulin genes and can promote mutations and DSB
followed by illegitimate chromosomal translocations in other
regions of the genome (Ramiro et al, 2004, 2006; Liu et al, 2008;
Robbiani et al, 2008, 2009). Importantly, chromosomal transloca-
tions are the hallmark of mature B-cell lymphomas, the most
frequent of all human lymphomas. Indeed, AID deficiency delays
the onset of lymphomagenesis in the mouse (Ramiro et al, 2004;
Kovalchuk et al, 2007; Pasqualucci et al, 2008), establishing a direct
link between AID collateral genotoxic activity and neoplastic trans-
formation in B lymphocytes.
In the last few years, it has become clear that AID expression is
not, as originally thought, exclusively restricted to activated B cells.
AID expression has been reported in several tissues, including
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gastric, hepatic, and gut epithelia (Endo et al, 2007, 2008;
Matsumoto et al, 2007; reviewed in Marusawa et al (2011)). AID
expression in these tissues is most frequently associated with
inflammatory conditions and the activation of the NF-jB pathway
(Endo et al, 2007; Matsumoto et al, 2007) and has been claimed
to promote the accumulation of mutations in epithelial cells
(Matsumoto et al, 2007, 2010; Takai et al, 2009; reviewed in
Marusawa et al (2011)). Given that chronic inflammation in epithe-
lial tissues predisposes to cancer development (Mantovani et al,
2008), the finding that the mutagenic activity of AID can be induced
in an inflammatory context has fostered the idea that AID might
contribute to or even constitute the link between inflammation and
cancer (Takai et al, 2012; reviewed in Marusawa et al (2011)).
Several gain-of-function mouse models have been generated to
address the contribution of AID to neoplastic transformation. Ubiq-
uitous AID overexpression led mostly to early T cell neoplasia
(Okazaki et al, 2003), hampering a thorough analysis of other
malignancies. In contrast, B-cell-specific AID overexpression did not
result in lymphomagenesis (Muto et al, 2006; Robbiani et al, 2009)
unless the tumor suppressor p53 was removed (Robbiani et al,
2009). However, to date, the impact of specific AID expression in
epithelial tissues, classically subject to inflammation-induced
neoplastic transformation, has not been addressed. Here, we aimed
to test this possibility directly by generating conditional knock-in
models of AID overexpression. AID expressed in colon and pancreas
epithelia was not sufficient to promote carcinogenesis, in spite of
being expressed at high levels and displaying genotoxic activity.
Instead, AID triggered the expression of NKGD2 ligands and the
recruitment of immune cells and promoted a cytotoxic response and
cell death. Our data indicate that the oncogenic potential of AID in
epithelial cells is neutralized by an immunosurveillance pathway
that prevents the expansion of pretumoral cells.
Results
Inflammation-induced AID does not contribute to carcinogenesis
Inflammation is known to play a critical role in the etiology of
colorectal and pancreatic ductal adenocarcinoma (reviewed in
Feagins et al (2009); Vonderheide & Bayne (2013)). To investigate
whether inflammatory conditions promote AID expression in these
tissues, we treated human epithelial cell lines derived from colorec-
tal adenocarcinoma (LoVo and SW480) and pancreatic adenocarci-
noma (AsPC and PaTU) with the pro-inflammatory cytokine TNF-a
and measured AID expression by qRT-PCR. TNF-a stimulation
increased AID mRNA expression in all cell lines analyzed (Fig 1A
and B). To assess whether primary, non-transformed cells were also
able to express AID in response to inflammatory stimuli, we gener-
ated explants from mouse pancreatic acinar cells and treated them
with TNF-a. As with the human tumor cells, mouse primary epithe-
lial cells expressed AID upon exposure to TNF-a (Fig 1C). TNF-a
treatment typically induced 4–30-fold increases in AID mRNA levels
in the different cell types tested, consistent with previous findings in
liver, gastric and colorectal cell lines (Endo et al, 2007, 2008;
Matsumoto et al, 2007). Together, these data confirm previous
results showing that inflammatory stimuli can trigger AID expression
in cell lines originated from human colorectal adenocarcinoma (Endo
et al, 2008), and show that pancreatic adenocarcinoma cells and
primary pancreatic cells are also responsive to TNF-a treatment.
Inflammation-induced AID expression has been proposed to
contribute to or even be the leading cause of some epithelium-
derived tumors, such as colorectal adenocarcinoma (Marusawa
et al, 2011). To address whether endogenous AID expressed in
epithelium under inflammatory conditions could contribute to
carcinogenesis, we made use of the well-established model of
dextran sulfate sodium (DSS)-induced colitis-associated cancer
(CAC) (Cooper et al, 2000). AID/ mice or AID+/ littermates
were treated for 10 cycles with 3% DSS and evaluated by pathologi-
cal criteria. We found that the frequency of oncogenic lesions was
not significantly different in AID/ versus AID+/ mice (Fig 1D).
We conclude that endogenous AID does not significantly contribute
to colorectal adenocarcinoma in the DSS-induced CAC model.
Conditional AID expression in epithelial cells does not promote
adenocarcinoma development
The absence of a significant contribution of endogenous AID to
carcinogenesis in DSS-treated mice could be explained by an insuffi-
cient amount of AID in this model. Indeed, AID expression is known
to be limiting for its activity in B cells (Sernandez et al, 2008), and
AID levels in B cells are typically 100–1,000 fold higher than those
detected in epithelial cells under inflammatory conditions (unpub-
lished observations). To directly evaluate whether AID expression
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Figure 1. Inflammation-induced AID expression does not contribute to
carcinogenesis.
A–C AID expression was analyzed in colon and pancreatic human cell lines
and in pancreas explants from C57BL/6 mice. Samples were treated as
indicated with 50 ng/ml TNF-a. (A) qRT–PCR analysis of AID expression in
LoVo and SW480 colon cell lines. n = 5 (LoVo); 3 (SW480). **P-value:
LoVo: 0.0017; SW480: 0.0079. (B) qRT–PCR analysis of AID expression in
AsPC and PaTU-8988S pancreatic cell lines (n = 2). *P-value: AsPC:
0.0369; PaTU-8988S: 0.0119. (C) qRT–PCR analysis of AID expression in
pancreatic explants from wild-type mice (n = 3). *P = 0.0242.
D AID/ or AID+/ mice were treated with 3% DSS for 10 cycles, and
colonic sections were analyzed by histologic inspection after H/E
staining. Graphs represent mean frequency values of adenoma and
adenocarcinoma lesions of five independent experiments. n = 28 (AID/
males); 35 (females); 23 (AID+/ males); 25 (females). P-value: male: 0.8;
female: 0.246.
Data information: All data are mean values  SEM. Statistical differences were
analyzed by two-tailed unpaired Student’s t-test.
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can contribute to carcinogenesis, we generated two mouse models
for conditional AID expression in epithelial cells of colonic and
pancreatic origin (Fig 2A). We introduced an AID-GFP-encoding
cassette in the endogenous Rosa26 locus preceded by a transcrip-
tional stop flanked by two loxP sites (R26AID+/KI mice). To achieve
specific expression of AID in epithelial cells, we bred R26AID+/KI
mice with mice expressing the Cre-recombinase under a villin
promoter, which specifically drives expression in colon (el Marjou
et al, 2004) (R26AID+/KIVillin-CRE+/TG mice), or the pancreas-
specific Ptf1 (p48) gene (Kawaguchi et al, 2002) (R26AID+/KI
p48-CRE+/KI mice). R26AID+/+Villin-CRE+/TG and R26AID+/+
p48-CRE+/KI mice were used as controls. To confirm that the
Rosa26 AID-GFP cassette was functional, we first evaluated the
expression of the reporter protein GFP by immunofluorescence in
colon of R26AID+/KIVillin-CRE+/TG mice and pancreas of R26AID+/KI
p48-CRE+/KI mice (Fig 2B). GFP was expressed in R26AID+/KI
Villin-CRE+/TG colon and R26AID+/KIp48-CRE+/KI pancreas but
not in control mice (Fig 2B) or in other tissues (not shown). We
next measured AID transcript levels by qRT-PCR. In R26AID+/KI
Villin-CRE+/TG and R26AID+/KIp48-CRE+/KI mice, the amount of
AID in the targeted epithelial tissues was similar to that found in
B cells activated in vitro with LPS + IL4, whereas AID expression
in control mice remained at background level (Fig 2C). AID is thus
expressed in the epithelium of R26AID+/KIVillin-CRE+/TG colon
and R26AID+/KIp48-CRE+/KI pancreas at levels known to be
functional in B cells.
To assess the contribution of AID to adenocarcinoma develop-
ment, we monitored tumor incidence in R26AID+/KIVillin-CRE+/TG
and R26AID+/KIp48-CRE+/KI mice. The onset of pancreatic and
colorectal adenocarcinoma in a variety of mouse models ranges from
5–6 months to 1–1.5 years (Fodde & Smits, 2001; Aguilar et al,
2004; Martinelli et al, 2015). Therefore, to avoid confounding results
arising from spontaneous tumorigenesis in very old mice, we set
analysis end points at 75–100 weeks. Survival of R26AID+/KI
Villin-CRE+/TG mice was indistinguishable from that of R26AID+/+
Villin-CRE+/TG littermate controls (Fig 2D, left). Likewise, survival
of R26AID+/KIp48-CRE+/KI did not differ from that of R26AID+/+
p48-CRE+/KI controls (Fig 2D, right). To rule out the presence of
early malignancies in aged animals, we performed thorough patho-
logical analysis of colon and pancreas sections of all animals, but
could not detect any tumor development in R26AID+/KIVillin-CRE+/TG
and R26AID+/KIp48-CRE+/KI animals at 75–100 weeks (Fig EV1).
Expression of AID in colon or pancreatic epithelial cells is thus not
sufficient to promote tumor development.
AID generates mutations and DNA double-strand breaks in
pancreatic epithelium
The failure of AID expression to trigger tumorigenesis prompted us
to evaluate its activity in epithelial cells. We first analyzed the
in vivo mutagenic activity of ectopically expressed AID. The primary
target sequences for AID mutagenic activity are immunoglobulin
genes; although other genes are known to be susceptible to AID-
induced mutagenesis, this occurs at much lower rates (~104 muta-
tions/bp) and the mechanisms responsible for this susceptibility are
poorly understood. One of the best-characterized requirements for
AID activity is that the target sequence be transcriptionally active
(Chaudhuri et al, 2003; Ramiro et al, 2003; Pavri & Nussenzweig,
2011). To simplify the mutagenesis analysis, we made use of the
p48 pancreatic AID expression model to take advantage of the
known low complexity transcriptome of acinar cells (MacDonald
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Figure 2. Heterologous AID expression does not promote carcinoma
development.
A Schematic of the constructs used for conditional expression of AID in
epithelial cells. An AID-IRES-GFP cassette preceded by a transcriptional
STOP flanked by LoxP sites was introduced by homologous recombination
within the endogenous Rosa26 locus (R26AID+/KI mice, top). R26AID+/KI mice
were bred with Villin-CRE and p48-CRE mice to achieve specific AID
expression in colon and pancreas, respectively (bottom).
B GFP immunofluorescence in colonic and pancreatic tissue from R26AID+/KI
VillinCRE+/TG and R26AID+/KIp48CRE+/KI mice. Scale bar: 50 lm.
C qRT–PCR analysis of AID expression in colonic and pancreatic tissue from
R26AID+/KIVillinCRE+/TG and R26AID+/KIp48CRE+/KI mice. n = 5 (R26AID+/+
VillinCRE+/TG); 4 (R26AID+/KIVillinCRE+/TG); 2 (R26AID+/+p48CRE+/KI);
2 (R26AID+/KIp48CRE+/KI). LPS+IL4-stimulated B cells are shown as a positive
control (n = 2). Bars show mean values  SEM normalized to LPS+IL4-
treated B cells.
D Kaplan–Meier survival curves for R26AID+/KIVillinCRE+/TG (left) (n = 47
(R26AID+/+ VillinCRE+/TG); 38 (R26AID+/KIVillinCRE+/TG)) and R26AID+/KI
p48CRE +/KI mice (right) (n = 39 (R26AID+/+p48CRE+/KI); 23 (R26AID+/KI
p48CRE+/KI)).
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et al, 2010). AID preferentially targets the consensus hotspots
WRCY/RGYW and particularly AGCT motifs (Rogozin & Kolchanov,
1992; Pham et al, 2003; Perez-Duran et al, 2012). Based on this, we
analyzed the presence of mutations in 800–900 bp downstream of
the transcriptional start site of two highly transcribed genes in
pancreas, Elastase1 (Ela1) and Elastase2 (Ela2a), by next-generation
sequencing, which allows large number of mutations to be analyzed
at a very high depth (Perez-Duran et al, 2012). This analysis
revealed that mutations are specifically accumulated at the Ela1 and
Ela2 genes in R26AID+/KIp48-CRE+/KI animals (Fig 3A and B) at
frequencies similar to those of other non-Ig genes in B cells (Liu
et al, 2008). AID activity was verified for Ela1 by conventional
Sanger sequencing (Table 1). In contrast to previous reports
(Matsumoto et al, 2007), we did not detect AID-induced mutations
at the tumor suppressor gene Trp53, where mutation frequency was
identical in R26AID+/KIp48-CRE+/KI mice and R26AID+/+p48-
CRE+/KI controls (Table 1).
To assess whether AID activity in R26AID+/KIp48-CRE+/KI mice
leads not only to mutations but also to more aggressive lesions,
such as DSBs, we quantified c-H2AX, a histone phosphorylation
produced in response to this type of DNA damage. For this analysis,
we generated acinar-cell explants from R26AID+/KIp48-CRE+/KI and
control mice, stained them with anti-cH2AX, and quantified the
intensity of staining per nucleus by high-throughput microscopy
(HTM). We found that AID expression in R26AID+/KIp48-CRE+/KI
mice promoted a significant increase in the levels of c-H2AX (Fig 3C
and D), indicating that AID generates DSBs in this cellular context.
AID induces NKG2D ligands, T cell recruitment and apoptotic cell
death in pancreas
Activation of the DNA damage response (DDR) pathway induces the
expression of NKG2D ligands in epithelial cells, which are in turn
recognized by NKG2D receptors expressed by NK cells and subsets
of T cells (Diefenbach et al, 2001; Gasser et al, 2005; Champsaur &
Lanier, 2010; Raulet et al, 2013). This cross talk promotes the elimi-
nation of precancerous cells and is therefore a mechanism to
prevent tumor development (Guerra et al, 2008). Given that AID
expression in pancreas promotes mutations and DNA damage with-
out leading to tumor development, we sought for the evidence of
precancerous cells and found that pancreas from aged R26AID+/KI
p48-CRE+/KI mice contained more proliferating cells, as assessed by
Ki67 staining, than control pancreas (Fig 4A), indicating that
pancreatic AID expression leads to an abnormal rate of cell division.
The epithelial identity of Ki67+ cells was confirmed both by
morphology (Fig 4A, magnified micrograph on the right) and by
staining with the epithelium-specific anti-cytokeratin 8 antibody
(Figs 4B and EV2). We next asked whether the NKG2D immune
surveillance pathway could be in play in R26AID+/KIp48-CRE+/KI
mice. To test this hypothesis, we first analyzed the expression of the
Raee NKG2D ligand in epithelial cells from pancreatic explants of
R26AID+/KIp48-CRE+/KI and control mice by flow cytometry.
Acinar cells from R26AID+/KIp48-CRE+/KI mice expressed higher
levels of Raee than their control littermates, although the difference
was not statistically significant (Fig 4C). To assess whether RAE
ligands were expressed by pancreatic cells in vivo, we prepared
pancreas extracts from aged (75-week-old) R26AID+/KIp48-CRE+/KI
mice and controls and measured the amount of five RAE isoforms
by droplet digital PCR (ddPCR). With this technique, each sample is
fractioned into thousands of droplets, in which PCR amplification
reactions occur independently, thereby increasing the sensitivity
and quantitative potential of the amplification. Amplification of RAE
isoforms was detected in more drops from R26AID+/KIp48-CRE+/KI
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Figure 3. AID expression in pancreas promotes DNA lesions.
A, B Analysis of AID mutagenic activity in Elastase1 (A) and Elastase2a (B) by
next-generation sequencing. Pancreatic DNA was isolated from pools of
R26AID+/KIp48CRE+/KI and control R26AID+/+p48CRE+/KI 20-week-old mice,
and then PCR-amplified with specific primers and sequenced as
previously described (Perez-Duran et al, 2012). Graphs show cytosine
mutation frequency overall (total) or at AGCT hotspots. n = 2. *P-value:
Elastase1: 0.0382; Elastase2a: 0.009.
C HTM-mediated quantification of cH2AX intensities per nuclei in pancreas
explants cultured in vitro for 6 days. Red lines show mean values. Results
of two independent experiments are shown. ****P < 0.0001.
D Representative images of cH2AX staining in pancreas explants from
R26AID+/+p48CRE+/KI (top) or R26AID+/KIp48CRE+/KI mice (bottom)
(40× magnification). White arrow points a representative positive cell.
Data information: Statistical differences were analyzed by two-tailed unpaired
Student’s t-test.
Table 1. Analysis of AID mutagenic activity by Sanger sequencing.
Genotype Total clones analyzed Mutations Total bp sequenced Frequency (×104)
Elastase1 R26AID+/+ p48-CRE+/KI 84 4 70,018 0.571
R26AID+/KI p48-CRE+/KI 82 13 69,355 1.87
Trp53 R26AID+/+ p48-CRE+/KI 66 0 59,472 0
R26AID+/KI p48-CRE+/KI 59 1 53,936 0.185
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samples than from controls (Fig 4D), indicating that AID promotes
the expression of NKG2D ligands in pancreas, most likely as a
result of DSB and DDR. We found that primary explants from
R26AID+/KIp48-CRE+/KI tended to be more sensitive to NK-mediated
killing than R26AID+/+p48-CRE+/KI littermate controls (Fig 4E),
indicating that NKG2D ligand expression in AID-expressing pancreas
is functional.
We next asked whether the expression of RAE ligands promoted
the recruitment of immune cells to R26AID+/KIp48-CRE+/KI
pancreas in vivo. Hematoxylin–eosin staining of pancreas sections
from aged mice clearly revealed the presence of immune infiltrates
in AID-expressing pancreas of R26AID+/KIp48-CRE+/KI mice
(Fig 5A). The composition of these immune infiltrates was analyzed
by antibody staining to detect macrophages (F4/80), B cells (Pax5)
and T cells (CD3). The vast majority of cells in the immune infil-
trates of R26AID+/KIp48-CRE+/KI mice were CD3+ T cells (Fig 5B),
with only a negligible contribution from B cells and macrophages
(not shown). To discount age-related effects, we analyzed 20-week-
old mice, finding that the accumulation of T cell infiltrates is detect-
able in these young animals (Fig 5C). The main NKG2D-expressing
T cell subset is the CD8+ population (Raulet et al, 2013), and
immunofluorescence analysis of immune infiltrates revealed that a
high proportion of the CD3+ infiltrate is composed of CD8+ T cells
(Fig 5C), a finding consistent with the reported recruitment of CTL
cells to pancreatic islets transgenically expressing Raee (Markiewicz
et al, 2012). Finally, we found that aged R26AID+/KIp48-CRE+/KI
mice had significantly higher levels of pancreatic TNF-a mRNA than
control littermates (Fig 5D), indicating that AID promotes the
expression of effector cytotoxicity. Consistently, R26AID+/KIp48-
CRE+/KI pancreas contained cells undergoing apoptotic cell death,
detected by caspase-3 immunohistochemistry (Fig 5E, P = 0.054).
Together, these results indicate that heterologous AID expression in
pancreas promotes a cytotoxic response, most likely arising from
the generation of genotoxic activity and NKG2D ligand expression
and the recruitment of NKG2D-expressing CTL cells.
Discussion
In recent years, the finding that inflammatory cues induce AID
expression in epithelial cells has boosted interest in the notion that
AID might promote carcinogenesis and even be the causative link
between inflammation and neoplastic transformation (Marusawa
et al, 2011; Takai et al, 2012). In this regard, our analyses of AID
expression in response to TNF-a have confirmed previous data in
colonic cell lines and have expanded these observations to
pancreatic cell lines. In addition, we found that primary pancre-
atic epithelium is also sensitive to TNF-a, suggesting that AID
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Figure 4. AID expression in pancreas promotes proliferation and NKG2D ligand expression.
A Representative images of Ki67 staining in pancreas from aged (75-week-old) R26AID+/+p48CRE+/KI (top) or R26AID+/KIp48CRE+/KI mice (bottom). Detail is shown on the
right. Scale bar: 100 lm. Graph shows quantification of Ki67-positive epithelial cells per mm2 of tissue (n = 8). *P = 0.0266.
B Representative immunofluorescence staining of 20-week-old R26AID+/KIp48CRE+/KI mice: blue, DAPI; red, Ki67; green, CK8. Scale bar: 50 lm. Detail is shown on the
bottom.
C Quantitative FACS analysis of RAE expression in pancreatic explants from R26AID+/+p48CRE+/KI and R26AID+/KIp48CRE+/KI mice. Left: Graph shows mean fluorescence
intensity. Each dot represents an individual mouse. n = 9 (R26AID+/+p48CRE+/KI); 8 (R26AID+/KIp48CRE+/KI). P = 0.077. Right: Representative FACS staining for RAE in
explants from R26AID+/+p48CRE+/KI (red) and R26AID+/KIp48CRE+/KI mice (black).
D Analysis of RAE expression by ddPCR in aged (75-week-old) mice. Data are presented as the percentage of positive drops normalized to the mean control value. Each
point represents an individual mouse and shows the mean amplification from two independent experiments n = 7 (R26AID+/+p48CRE+/KI); 9 (R26AID+/KIp48CRE+/KI).
*P = 0.012.
E Analysis of killing activity. Primary explants of pancreatic cells from R26AID+/+p48CRE+/KI or R26AID+/KIp48CRE+/KI mice were cultured with primary NK cells, and killing
activity was assessed as described in Materials and Methods (n = 4). P = 0.19.
Data information: Statistical differences were analyzed by two-tailed unpaired Student’s t-test.
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expression can indeed take place in vivo in pro-inflammatory
contexts.
We wanted to further explore the physiological relevance of AID
expression in promoting epithelium malignant transformation. We
found that AID deficiency does not reduce the incidence of onco-
genic lesions in an inflammation-induced carcinoma model. Our
results contrast with the finding that AID deficiency reduces colon
carcinogenesis in IL10/ mice (Takai et al, 2012). It may be that
the effect reported by Takai et al is not specifically driven by epithe-
lial cells, but rather by B cells in IL10/ mice, a possibility that
could be tested using conditionally rather than constitutively AID-
deficient animals.
Previous reports have claimed that AID heterologous expression
leads to epithelial cell neoplasia in various tissues (Endo et al, 2008;
Takai et al, 2009, 2012; Marusawa et al, 2011). In those studies,
overexpression was always achieved with transgenes, none of
which was epithelium specific, and the incidence of neoplasias was
extremely low, and varied with the insertion sites and with ongoing
mouse generations (Okazaki et al, 2003). In contrast, here we have
developed epithelium-specific conditional knock-in models, thus
avoiding both widespread expression and transgene-derived arti-
facts. Remarkably, our models allowed B-cell-like AID expression
levels, a basic prerequisite for AID to be competent, given that its
levels are rate limiting in its native context (Sernandez et al, 2008;
Takizawa et al, 2008). We found that AID expressed ectopically in
pancreatic cells is able to mutate non-immunoglobulin genes and to
generate genotoxic DSBs, suggesting that in this context, there are
no obvious mechanisms for negative regulation of AID activity, as
they were previously proposed for transgenic AID expression in
B cells (Muto et al, 2006). AID mutagenic activity was detected in
two highly expressed pancreatic genes (Ela1 and Ela2), which is
expected from the well-established link between AID activity and
transcription of its target genes (Chaudhuri et al, 2003; Ramiro et al,
2003; MacDonald et al, 2010; Pavri & Nussenzweig, 2011).
Our data indicate that AID activity in pancreas does not promote
pancreatic carcinogenesis; instead, it triggers an NKG2D-mediated
cytotoxic response that would eliminate pretumoral cells and
prevent carcinoma development, in line with the published finding
**
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Figure 5. AID expression in pancreas promotes immune infiltration and cell death.
A Hematoxylin–eosin (HE) staining of pancreas from aged (75-week-old) R26AID+/+p48CRE+/KI and R26AID+/KIp48CRE+/KI mice. Left: Representative HE staining showing
an immune infiltrate in a R26AID+/KIp48CRE+/KI mouse. Scale bar: 200 lm. Right: Quantification of number of foci per mm2 of tissue. n = 13 (R26AID+/+p48CRE+/KI);
21 (R26AID+/KIp48CRE+/KI). **P = 0.0098.
B CD3 immunohistochemistry of pancreas from 75-week-old R26AID+/+p48CRE+/KI and R26AID+/KIp48CRE+/KI mice. Left: Representative image of a CD3 infiltrate
in a R26AID+/KIp48CRE+/KI mouse. Scale bar: 100 lm. Right: Quantification of the number of CD3-positive cells per mm2 of tissue. n = 12 (R26AID+/+p48CRE+/KI);
13 (R26AID+/KIp48CRE+/KI). *P = 0.0149.
C Representative immunofluorescence staining of CD3 and CD8 in pancreas from 20-week-old R26AID+/+p48CRE+/KI and R26AID+/KIp48CRE+/KI mice. Scale bar: 20 lm.
D TNF-a expression. Total RNA was isolated from pancreas of aged (75-week-old) R26AID+/KIp48CRE+/KI and control mice, and TNF-a expression was quantified by
qRT-PCR. Each dot represents an individual mouse. n = 8 (R26AID+/+p48CRE+/KI); 15 (R26AID+/KIp48CRE+/KI). *P = 0.0392.
E Cell death detection. Pancreas from 75-week-old R26AID+/+p48CRE+/KI and R26AID+/KIp48CRE+/KI mice were stained with anti-caspase-3. Left: Representative staining
from an R26AID+/+p48CRE+/KI mouse (top) and an R26AID+/KIp48CRE+/KI mouse (bottom). Scale bar: 50 lm. Right: Quantification of number of cells per mm2 of tissue.
Each dot represents an individual mouse. n = 9 (R26AID+/+p48CRE+/KI); 11 (R26AID+/KIp48CRE+/KI). P = 0.0545.
Data information: Statistical differences were analyzed by two-tailed unpaired Student’s t-test.
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that AID promotes an NKG2D immune response in B cells infected
with the Abelson murine leukemia virus (Gourzi et al, 2006). The
lymphomagenic potential of AID was previously shown to be damp-
ened in B cells (Muto et al, 2006; Robbiani et al, 2009), where p53
exerts a cell-intrinsic tumor suppressor function (Robbiani et al,
2009). Here, we provide evidence of a further protective mechanism
triggered by AID activity and carried out through an extrinsic
immunosurveillance pathway in epithelial tissues. These data high-
light the diversity of safeguarding events in AID-expressing cells and
encourage a refined view of the previously acknowledged contribu-
tion of endogenous AID to epithelial-derived tumors.
Materials and Methods
Mice
R26AID mice were generated by insertion of a construct encoding
mouse AID cDNA into the Rosa26 IRES-GFP targeting vector (Nyabi
et al, 2009). AID cDNA was PCR-amplified from C57BL/6 mice
(primers: forward 50-TTCTGTGAAGACCGCAAGGCT-30; reverse
50-CCCTTCCCAGGCTTTGAAA-30), cloned into the pENTR/D-TOPO
Gateway vector (Invitrogen), and subsequently recombined into the
Rosa 26 targeting vector, in which the cloned construct is preceded
by a loxP-flanked transcriptional stop cassette and followed by an
internal ribosomal entry site and GFP. The construct was linearized
with PvuI before electroporation into hybrid 129/C57BL/6 ES cells.
Clones positive for homologous recombination in the Rosa26 locus
were identified by Southern blot of EcoRV-digested genomic DNA
hybridized with a 50-arm Rosa26 probe. R26AID mice were back-
crossed to C57BL/6 background for 5 generations. R26AID mice
were crossed with Villin-CRE+/KI mice (el Marjou et al, 2004) and
p48-CRE+/KI mice (Kawaguchi et al, 2002) to promote expression of
AID in colonic and pancreatic epithelial cells, respectively. Both
Villin-CRE and p48-CRE mice were backcrossed to C57BL/6 for 5
generations. Balb/c AID/ mice were generated by backcrossing
AID/ mice (Muramatsu et al, 2000) for 6 generations by speed
congenics (Ramiro et al, 2004). Mice of both genders were used
unless specified otherwise. All animals were housed in the Centro
Nacional de Investigaciones Cardiovasculares animal facility under
a 12-h light/dark cycle with food ad libitum.
Number of animals per group to detect biologically significant
effect sizes was calculated using appropriate statistical sample size
formula and indicated in the biometrical planning section of the
animal license submitted to the governing authority. Blinding and
randomization was not applicable to the animal studies. All animal
procedures conformed to EU Directive 2010/63EU and Recommen-
dation 2007/526/EC regarding the protection of animals used for
experimental and other scientific purposes, enforced in Spanish law
under RD 53/2013.
Cell lines and primary acinar cell culture
Primary pancreatic acinar cells were isolated and cultured as
described in Gout et al (2013). Briefly, complete pancreas from
8-week-old mice was mechanically and enzymatically digested with
collagenase to obtain isolated acinar structures. Acini were grown in
Waymouth’s medium supplemented with 2.5% FBS, 10 mM HEPES,
0.25 mg/ml trypsin inhibitor (Sigma) and 25 ng/ml of recombinant
human epidermal growth factor (Sigma). PaTU-8988S, AsPC-1, LoVo
and SW480 cells were grown in DMEM supplemented with 10% FCS
and 10 mM HEPES. PaTU-8988S cell line was kindly provided by Dr
Thomas Gress (University of Marburg). AsPC-1, LoVo and SW480
cell lines were obtained from the ATCC. All of them were myco-
plasma negative. TNF-a (50 ng/ml) was added when indicated.
DSS-induced colitis-associated cancer (CAC) experiments
8–10-week-old Balb/c AID+/ and AID/ (Ramiro et al, 2004)
mice were given 3% dextran sulfate sodium salt (DSS, Sigma) in
their drinking water for 5 days followed by regular drinking water
for 10 days. Colon samples were obtained from these mice after 10
cycles of DSS treatment, and Swiss roll preparations were fixed,
embedded in paraffin for section, and stained with hematoxylin/
eosin (H/E).
Immunofluorescence
Pancreas and colon specimens were fixed with 4% paraformalde-
hyde, incubated with 30% sucrose, embedded in OCT compound
(Olympus), and frozen in dry ice. 10-lM sections were permeabi-
lized and blocked with Image-It FX signal enhancer (Invitrogen,
Molecular Probes). The following antibodies were used: rabbit anti-
GFP (Abcam, 1/100), rat anti-mouse CD8a (BD Pharmingen, 1/100),
mouse anti-Cytokeratin 8 (TROMA I, 1/50), goat anti-rabbit Alexa
Fluor 488 (Molecular Probes, 1/500), goat anti-mouse Alexa Fluor
488 (Molecular Probes, 1/500), and goat anti-rat Cy3 (Jackson
ImmunoResearch, 1/500). Slides were mounted with Vectashield
mount medium containing DAPI (Vector Laboratories).
Immunohistochemistry
Pancreases were fixed in neutral-buffered 10% formalin solution
(Sigma), embedded in paraffin blocks, and cut in 5-lM sections.
H/E staining was performed using standard protocols. For immuno-
histochemistry, sodium citrate buffer was used for antigen retrieval.
The following antibodies were used: polyclonal rabbit anti-human
CD3 (Dako, 1/200), rabbit anti-Ki67 (Abcam, 1/100), and biotiny-
lated goat anti-rabbit (Abcam, 1/200). Biotinylated antibody was
detected with the ABC system using diaminobenzidine as substrate
(Vector Laboratories). Images were acquired with a Leica DM2500
microscope fitted with a 20× magnification lens. Reactive cells from
10 microscope fields per pancreas were counted using ImageJ.
Results are shown as the number of reactive cells per mm2 of tissue.
qRT–PCR
RNA was extracted from colon samples with TRIzol (Sigma). RNA
from pancreas samples was extracted with GTC solution, following
a standard phenol–chloroform protocol (reagents from Sigma),
followed by DNAse treatment (Qiagen). cDNA was synthesized
using Random Hexamers (Roche) and SuperScript II reverse tran-
scriptase. mRNA was quantified by SYBR green assay (Applied
Biosystems), with normalization to GAPDH. The following primers
were used: human-AID (forward) 50-AAA TGT CCG CTG GGC TAA
GG-30, (reverse) 50-GGA GGA AGA GCA ATT CCA CGT-30;
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human-GAPDH (forward) 50-GAA GGT GAA GGT CGG AGT C-30,
(reverse) 50-GAA GAT GGT GAT GGG ATT TC-30; mouse AID (for-
ward) 50-ACC TTC GCA ACA AGT CTG GCT-30, (reverse) 50-AGC
CTT GCG GTC TTC ACA GAA-30; mouse-GAPDH (forward) 50-TGA
AGC AGG CAT CTG AGG G-30, (reverse) 50-CGA AGG TGG AAG
AGT GGG AG-30; mouse-TNF-a (forward) 50-AGC CCA CGT CGT
AGC AAA CCA-30, (reverse) 50-ACA ACC CA CGG CTG GCA CC-30.
Next-generation sequencing for detection of mutations
DNA from three R26AID+/+p48-CRE+/KI and three R26AID+/KI
p48-CRE+/KI mice was extracted and amplified using the following
oligonucleotides: Elastase1 (forward) 50-GCA CAG CAT CTT TTG
TTT GGG TAA-3′, (reverse) 50-GGG GAC AGT GGT CTA CTC TCT-30;
Elastase2a (forward) 50-ACG AGT CCA GGA CAA TCA GAG A-30,
(reverse) 50-TGA TAA GGC CAC TCA TAA AAA GGA-30. Amplifi-
cation reactions were carried out with 2.5 U of Pfu Ultra
(Stratagene) in a 50-ll reaction with the following profile: 94C for
5 min followed by 25 cycles at 94C for 10 s, 60C for 30 s, and
72C for 1 min. For NGS sequencing, the PCR product from two
reactions per mouse were pooled, and an equimolar amount of DNA
from each of the two mouse genotypes was pooled and mixed.
c-H2AX staining and Opera acquisition
Primary pancreatic acinar cells were grown on 96-well plates
(Perkin Elmer), and c-H2AX (Millipore, 1/500) immunofluorescence
was performed using standard procedures. Images were automati-
cally acquired from each well with the Opera High-Content Screen-
ing System (Perkin Elmer). A 40× magnification lens was used, and
pictures were taken at nonsaturating conditions. Images were
segmented using DAPI staining to generate masks matching cell
nuclei, and the mean per-cell c-H2AX signal was calculated.
Droplet digital PCR
Each 20 ll ddPCR contained 10 ll of 2× ddPCR Supermix (Bio-Rad),
1 ll of cDNA generated from 1.4 lg of RNA, and 500 nM of each
primer: pan-RAE (forward) 50-TGG ACA CTC ACA AGA CCA ATG-30,
(reverse) 50-CCC AGG TGG CAC TAG GAG T-30; and 250 nM
Taqman probe (panRAE-FAM 50-CCA TGA TTT ATC CGC AAA GCC
AGG GCC-30). After droplet generation, a mean of 12,000 droplets
was obtained per sample.
Samples were transferred into a 96-well plate (Eppendorf) and
cycled in a thermal cycler (Bio-Rad) under the following conditions:
95C for 10 min followed by 38 cycles of 94C for 30 s, 58C for
1 min, and a final step at 98C for 10 min. After amplification,
samples were transferred to a droplet reader (QX100 Droplet Digital
PCR, Bio-Rad) from which positive-drop data were extracted with
Quantasoft software. Results are represented as the proportion of
positive drops in duplicates of each sample.
NK killing assay in vitro
Primary pancreatic acinar cells from R26AID+/+p48-CRE+/KI and
R26AID+/KIp48-CRE+/KI mice were isolated as described above.
After 6 days of culture, acinar cells were trypsinized and stained
with CFSE. NK cells were isolated by cell sorting from wild-type
C57BL/6 mice. Both male and female aged 6–8 weeks were used as
NK cells donors. NK cells and acinar pancreatic cells were co-
cultured for 4 h in the presence of IL2 (2,000 U/ml, Peprotech) at a
1:10 (target cell:NK effector cell) ratio. Killing was analyzed by
staining with DAPI by flow cytometry. Data are presented as the
proportion of CFSE+DAPI+ cells normalized to the same population
in cultures lacking NK cells.
Statistics
Statistical analyses were performed with GraphPad Prism (version
6.01 for Windows, GraphPad Software, San Diego, CA, USA) using
two-tailed Student’s t-test. P ≤ 0.05 was considered statistically
significant. Error bars in figures represent standard error of the
mean (SEM). Normal distribution of data was assessed by applying
a D’Agostino & Pearson omnibus normality test. F-test was used to
compare variances between groups. For the survival analyses,
GraphPad Prism was used and the Mantel–Cox test was applied.
Differences were considered statistically significant at P ≤ 0.05.
Expanded View for this article is available online:
http://embomolmed.embopress.org
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The paper explained
Problem
AID is a DNA-modifying enzyme expressed in germinal center B cells
and required for the adaptive immune response, and its activity is
linked to B cell neoplasias. A number of studies have reported AID
expression in epithelial cells, usually associated with inflammatory
cues. However, the contribution of AID expression to carcinogenesis
remains controversial.
Results
We have developed conditional mouse models to promote epithelial-
specific AID expression in pancreas and colon and found that despite
high levels of AID expression and activity, these mice do not develop
carcinomas. Instead, AID genotoxicity in pancreas promotes a response
that involves NKG2D ligand expression, CD8+ T cell recruitment, and
epithelial cell death. Therefore, our data provide evidence that AID-
expressing epithelia are protected from neoplastic transformation by
an NKG2D surveillance pathway.
Impact
Our results uncover a new protective mechanism counter-acting AID
oncogenic potential through an extrinsic immunosurveillance pathway
in epithelial cells. These findings challenge the view that AID could
contribute significantly to inflammation-related carcinogenesis.
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